The SDHA Gene Cardiomyopathy Dilated Type 1GG Genetic Test is a specialized diagnostic examination designed to identify mutations in the SDHA gene, which have been linked to Dilated Cardiomyopathy (DCM) of type 1GG. DCM is a condition characterized by the dilation and impaired contraction of the left ventricle or both ventricles of the heart, which can lead to heart failure and other serious cardiovascular complications. The SDHA gene plays a crucial role in the mitochondrial respiratory chain, which is essential for energy production within cells, including heart muscle cells.
This genetic test is a critical tool for individuals with a family history of DCM or those who exhibit symptoms suggestive of this condition, enabling early detection and management of the disease. By analyzing the patient's DNA for specific mutations in the SDHA gene, healthcare providers can offer personalized treatment plans, potentially improving outcomes and quality of life for affected individuals.
The test is available at DNA Labs UAE, a leading facility in genetic testing and analysis, ensuring high-quality, accurate results. The cost of the SDHA Gene Cardiomyopathy Dilated Type 1GG Genetic Test is 4400 AED. This investment in health can provide invaluable information for patients and their families, guiding decisions about lifestyle, medical management, and potential preventive measures against the progression of dilated cardiomyopathy.
The "BAG3 Gene Cardiomyopathy Dilated Type 1HH Genetic Test" is a specialized diagnostic procedure offered by DNA Labs UAE, designed to detect mutations in the BAG3 gene, which are linked to Dilated Cardiomyopathy (DCM) type 1HH. Dilated Cardiomyopathy is a condition characterized by the heart's diminished ability to pump blood due to an enlarged and weakened left ventricle. The BAG3 gene plays a crucial role in cardiac function and structure, and mutations in this gene can lead to early-onset DCM, often resulting in severe cardiac issues or heart failure.
This genetic test is critical for individuals with a family history of DCM or symptoms suggestive of the condition, as it can provide definitive diagnosis and guide treatment decisions. The test involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed in the lab to identify any genetic alterations in the BAG3 gene.
The cost of the test is 4400 AED, reflecting the specialized nature of the genetic analysis and the comprehensive insights it offers into the patient's condition. By identifying BAG3 gene mutations, healthcare providers can better understand the disease's progression, enabling more personalized and effective treatment plans, and potentially guiding family planning decisions for affected individuals or their relatives.
The DES Gene Cardiomyopathy Dilated Type 1I Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the DES gene that are associated with Dilated Cardiomyopathy (DCM) type 1I. This condition is a form of heart disease where the heart's ability to pump blood is decreased because the heart's main pumping chamber is enlarged and weakened. Individuals with mutations in the DES gene may have a higher risk of developing DCM, which can lead to heart failure and other serious complications if left untreated.
The test is crucial for individuals with a family history of DCM or those exhibiting symptoms related to heart diseases, as it allows for early detection and management of the condition. The process involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory for any genetic abnormalities in the DES gene.
At DNA Labs UAE, the cost of the DES Gene Cardiomyopathy Dilated Type 1I Genetic Test is set at 4400 AED. The investment in this test is valuable for at-risk individuals, providing essential information that can guide healthcare decisions, including preventive measures and personalized treatment plans to manage or mitigate the impact of DCM. Early detection through genetic testing is a proactive step towards maintaining heart health and preventing the progression of the disease.
The BRAF Gene Cardiofaciocutaneous Syndrome Genetic Test is a specialized diagnostic procedure designed to identify mutations in the BRAF gene, which are known to cause Cardiofaciocutaneous (CFC) syndrome. CFC syndrome is a rare genetic condition that affects various parts of the body, including the heart, facial features, and skin. Symptoms may include heart defects, developmental delays, distinctive facial characteristics, and skin abnormalities.
This test is conducted at DNA Labs UAE, a leading facility in genetic testing and analysis. The test involves collecting a DNA sample, typically through a blood draw or cheek swab, and examining it for specific mutations in the BRAF gene that are associated with CFC syndrome. This genetic test is crucial for confirming a diagnosis of CFC syndrome, which can enable appropriate management and treatment plans for the affected individuals.
The cost of the BRAF Gene Cardiofaciocutaneous Syndrome Genetic Test at DNA Labs UAE is 4400 AED. This investment in genetic testing can provide vital information for affected families, aiding in understanding the condition, planning for medical care, and accessing support services. It's important for potential patients or their guardians to consult with a healthcare provider or a genetic counselor to discuss the benefits, limitations, and implications of this test.
The KRAS Gene Cardiofaciocutaneous Syndrome Genetic Test is a specialized diagnostic procedure designed to identify mutations in the KRAS gene, which are linked to Cardiofaciocutaneous Syndrome (CFC). CFC is a rare genetic condition that affects the heart, facial features, and skin. Symptoms often include heart defects, distinctive facial characteristics, skin abnormalities, and developmental delays. This genetic test is crucial for the accurate diagnosis of CFC, enabling healthcare providers to offer appropriate management and treatment plans tailored to the patient's specific needs.
Performed at DNA Labs UAE, the test involves analyzing the patient's DNA to look for specific mutations in the KRAS gene that are known to cause CFC. The process is meticulous, ensuring high accuracy and reliability of the results. Given the complexity and the specialized technology required for this genetic analysis, the cost of the test is set at 4400 AED.
Undergoing this test at DNA Labs UAE ensures that patients receive a comprehensive evaluation by experts in genetic diagnostics. The lab's state-of-the-art facilities and adherence to international standards of quality and confidentiality make it a trusted choice for genetic testing in the region.
The "GATA6 Gene Atrial Septal Defect Type 9 Genetic Test" is a specialized diagnostic tool offered by DNA Labs UAE, aimed at detecting mutations in the GATA6 gene, which are associated with Atrial Septal Defect Type 9 (ASD9). Atrial Septal Defect is a congenital heart condition characterized by a hole in the wall (septum) that divides the upper chambers (atria) of the heart. The GATA6 gene plays a crucial role in the development and function of the heart and lungs, and mutations in this gene can lead to various cardiac anomalies, including ASD9.
This genetic test is vital for individuals with a family history of heart defects, or those showing symptoms of ASD9, as it can provide a definitive diagnosis, enabling timely and appropriate medical interventions. The test involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed for the presence of mutations in the GATA6 gene.
The cost of the GATA6 Gene Atrial Septal Defect Type 9 Genetic Test at DNA Labs UAE is 4400 AED. This cost reflects the specialized nature of the test and the comprehensive analysis required to identify the genetic mutation. Getting tested at a reputable facility like DNA Labs UAE ensures accuracy and reliability of the results, which is crucial for the management and treatment of the condition.
The "GATA4 Gene Atrioventricular Septal Defect Type 4 Genetic Test" is a specialized diagnostic examination offered by DNA Labs UAE, designed to identify mutations in the GATA4 gene that are associated with Atrioventricular Septal Defect (AVSD) Type 4. AVSD is a congenital heart defect characterized by a combination of holes between the heart's chambers and abnormalities in the valves that regulate blood flow in the heart. The GATA4 gene plays a crucial role in the development of the heart, and mutations in this gene can lead to various cardiac malformations, including AVSD.
This genetic test is crucial for early detection and management of AVSD Type 4, allowing for timely intervention and treatment planning. It involves collecting a DNA sample, typically through a blood draw, and analyzing it for specific mutations in the GATA4 gene that have been linked to this condition. The test is priced at 4400 AED and is available at DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates. By offering this test, DNA Labs UAE aids in the diagnosis and understanding of AVSD Type 4, contributing to better patient outcomes through personalized medical care.
The "GATA6 Gene Atrioventricular Septal Defect Type 5 Genetic Test" is a specialized diagnostic procedure designed to detect mutations in the GATA6 gene, which are linked to the development of Atrioventricular Septal Defect Type 5 (AVSD5). This condition is a congenital heart defect characterized by abnormalities in the heart's structure that affect the atrial and ventricular septa and the atrioventricular valves, leading to compromised cardiac function. The test is crucial for early detection and management of the condition, allowing for tailored treatment plans that can significantly improve the quality of life for affected individuals.
Performed at DNA Labs UAE, a leading facility in genetic testing, the test leverages advanced genetic sequencing technologies to accurately identify the presence of mutations in the GATA6 gene. The cost of the test is 4400 AED, reflecting the sophisticated nature of the technology and the expertise required to interpret the results. This test is particularly valuable for families with a history of AVSD5, as it can provide essential information for prospective parents or for individuals who may be at risk. Early diagnosis through this test can enable timely medical interventions, including surgery or medication, to address the structural heart issues associated with the defect, potentially preventing more severe complications.
The TAZ Gene Barth Syndrome Genetic Test is a crucial diagnostic tool used to identify Barth Syndrome, a rare genetic disorder primarily affecting males. This test specifically targets mutations in the TAZ gene, which are responsible for the development of the syndrome. Barth Syndrome is characterized by cardiomyopathy (a condition that affects the heart muscle), neutropenia (a decrease in the number of white blood cells), muscle weakness, and growth delays. Early detection through the TAZ Gene test allows for appropriate management and treatment of the condition, improving the quality of life for those affected.
The test is available at DNA Labs UAE, a leading facility in genetic testing and analysis. The cost of the TAZ Gene Barth Syndrome Genetic Test is 4400 AED. DNA Labs UAE employs cutting-edge technology and methodologies to ensure accurate and reliable results, providing essential information for the diagnosis and management of Barth Syndrome.
The "TIMP1 Gene Bicuspid Aortic Valve Genetic Test" is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the TIMP1 gene, which have been associated with the development of bicuspid aortic valve (BAV) disease. Bicuspid aortic valve is a congenital heart defect where the aortic valve has only two leaflets instead of the normal three, potentially leading to complications such as aortic valve stenosis or regurgitation, and increasing the risk of aortic aneurysm and dissection.
This genetic test is crucial for individuals with a family history of BAV or related aortic pathologies, as it can provide valuable insights into their risk of developing this condition. Early detection through genetic testing can facilitate timely medical intervention, improving patient outcomes through monitoring and management of potential cardiovascular complications associated with BAV.
The test is performed using a blood sample, which is analyzed to detect any genetic variations in the TIMP1 gene that may indicate a predisposition to developing a bicuspid aortic valve. The cost of the test is 4400 AED, reflecting the specialized nature of the analysis and the comprehensive information it provides, which can be pivotal in guiding clinical decisions and patient care plans.
By offering this genetic testing service, DNA Labs UAE plays a vital role in the early detection and management of bicuspid aortic valve disease, contributing to the advancement of personalized medicine and cardiovascular health.
